Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for SPIRONOLACTONE
- Efficacy and Safety of Finerenone vs. Spironolactone in Patients With Primary Aldosteronism
- Heart Failure Polypill at a Safety Net Hospital
- A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
- Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
- Comparing the Efficacy and Safety of Finerenone and Spironolactone in the Treatment of Primary Aldosteronism
- Spironolactone in Alcohol Use Disorder (SAUD)
- Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment
- Patiromer Trial in CKD Stage IIIB to V
- Quadruple Immunotherapy for Neuroblastoma
- Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
- Effect of a Proposed Cav1.3 Inhibitor in Primary Aldosteronism
- Dapagliflozin, Spironolactone or Both for HFpEF
- Effect of Dapagliflozin on VT in Patients With Heart Failure.
- The Effect of SAAE on Ventricular Remodeling in PA Patients
- A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
- The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients
- Probiotics and Hemodynamic Changes in Cirrhosis
- Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden
- Spironolactone in CKD Enabled by Chlorthalidone: PILOT
- Value of Potassium Magnesium Citrate in Preventing and Treating Hypertension in African Americans
- Evaluation of Spironolactone Efficacy in Patient With Rheumatoid Arthritis (RA)
- Efficacy and Safety of Midodrine in Refractory or Recurrent Ascites in Children With Cirrhosis.
- Transgender Estradiol Affirming Therapy
- Lokelma for RAAS Maximisation in CKD & Heart Failure.
- Mineralocorticoid Receptor Antagonist and Pulmonary Fibrosis in COVID-19.
- Fibrosis and the Fontan
- Non-Responsive Diabetic Macular Edema and Spironolactone
- Spironolactone and Dexamethasone in Patients Hospitalized With COVID-19
- Effects of Adding Hypertonic Saline Solutions and/or Etilefrine to Standard Diuretics Therapy in Hepatic Ascites
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage (REDUCE)
- Spironolactone In The Treatment of Heart Failure
- Does Spironolactone Normalize Sleep-wake Luteinizing Hormone Pulse Frequency in Pubertal Girls With Hyperandrogenism?
- Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis.
- Study to Assess Efficacy and Safety of SZC for the Management of High Potassium in Patients With Symptomatic HFrEF Receiving Spironolactone
- Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS
- Polypill Strategy for Heart Failure With Reduced Ejection Fraction
- Diuretic and Natriuretic Effect of High-dose Spironolactone in Patients With Acute Heart Failure
- Weekly Isotretinoin Therapy Study
- Comparative Effectiveness Study of Spironolactone Versus Doxycycline for Acne
- Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
- Antiarrhythmic Effects of Spironolactone in Patients With ICDs
- Early Sequential Nephron Blockade in Acute Heart Failure Patients: A Randomised, Controlled Study
- The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart Failure
- BromhexIne And Spironolactone For CoronаVirUs Infection Requiring HospiTalization
- The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.
- Pilot Study on Withdrawal of Spironolactone Among Heart Failure With Improved Ejection Fraction
- Spironolactone in Covid-19 Induced ARDS
- Comparison of Spironolactone and Amiloride on Home Blood Pressure in Resistant Hypertension
- Evaluating Drug Interactions Between Doravirine With Estradiol and Spironolactone in Healthy Transgender Women
- Tissue K+ in Primary Hyperaldosteronism
- Spironolactone to Improve Apnea and Cardiovascular Markers in Obstructive Sleep Apnea Patients
- AuTophagy Activation for Cardiomyopathy Due to Anthracycline tReatment (ATACAR)Trial
- Calcium Channel Blockade in Primary Aldosteronism
- RELieving Increasing oEdema Due to Heart Failure
- Spironolactone for Hidradenitis Suppurativa
- Does Treatment of Androgen Excess Using Spironolactone Improve Ovulatory Rates in Girls With Androgen Excess?
- Safety and Efficacy of Early, seQUential Oral dIuretic Nephron blockAde In Acute Heart Failure
- Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential Interactions Between Truvada and Hormone Therapy
- A Registry-based Cluster Randomized Trial to Compare the Effect of Spironolactone vs. Eplerenone on Clinical Outcomes in Patients With Symptomatic Systolic Heart Failure
- Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents
- Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients
- Spironolactone for the Treatment of Melasma
- Efficacy of Aldosterone Antagonist Therapy for Prevention of New Atrial Fibrillation
- Pressure Assessment to Improve Outcomes After TAVR: a Registry
- Drug-drug Interaction (DDI) Study of Spironolactone (Perpetrator) and Digoxin (Substrate Drug)
- Venetoclax and Lintuzumab-Ac225 in AML Patients
- Continuous Versus Cyclical OCP Use in PCOS
- Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy
- Spironolactone Versus Prednisolone in DMD
- Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade
- Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome
- Adjuvant Anti-Mineralocorticoid-Receptor Treatment in Anti-VEGF Refractory Neovascular Age-Related Macular Degeneration
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
- ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)
- Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium
- Spironolactone Versus Indapamide in Obese and Hypertensive Patients
- Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On
- Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
- Spironolactone Therapy In Young Women With NASH
- Spironolactone and Perioperative Atrial Fibrillation Occurrence in Cardiac Surgery Patients.
- Management of Decompensated HCV Cirrhotic Patients
- Clinical Efficacy of Potassium Canrenoate in Sinus Rhythm Restoration Among Patients With Atrial Fibrillation.
- Safety and Efficacy of Two Year Spnol and Maximal R Blockad Therapy
- Hypoglycemia and Autonomic Nervous System Function-B
- Clinical Study of UMOD NKCC2 Interaction on Salt-sensitivity in Hypertension
- Spironolactone Therapy in Chronic Stable Right HF Trial
- Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.
- The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
- Prevention of the Progression of Coronary Calcification With Use of Spironolactone in Peritoneal Dialysis Patients
- Exploring Mechanisms and Morphology of QT Interval Prolongation
- A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women
- Mechanisms of Refractory Hypertension (Reserpine)
- Spironolactone on Acute Kidney Injury in Critically Ill Patients
- The Impact of Fitness and Mineralocorticoid Receptor Blockade on Vascular Dysfunction in Adults With Type 1 Diabetes
- Matão Controlling Hypertension (MatCH Study): Rationale and Design
- Spironolactone With Patiromer in the Treatment of Resistant Hypertension in Chronic Kidney Disease
- Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- Colchicine and Spironolactone in Patients With MI / SYNERGY Stent Registry
- Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
- Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy
- Spironolactone on Fibrosis Progrssion-Portal Hypertension(FP-PH)in Cirrhosis
- Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
- Spironolactone After Liver Transplant
- Adipose Tissue Derived Stem Cell Based Hair Restoration Therapy for Androgenetic Alopecia
- Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
- Sequential Nephron Blockade vs. Dual Blockade Renin-angiotensin System + Bisoprolol in Resistant Arterial Hypertension
- High-dose Aldosterone Antagonist for Acute Decompensated Heart Failure
- Metabolic Effects of Furosemide +HSS in Refractory Ascites
- Withdrawal of Medication in Recovered DCM
- Inhibition of Aldosterone to Reduce Myocardial Diffuse Fibrosis in Patients With Paroxysmal and Persistent Atrial Fibrillation in Preventing Recurrent Episodes of Atrial Fibrillation
- Effects of Cyproterone Compound-spironolactone, Metformin and Pioglitazone on Inflammatory Markers in PCOS
- Spironolactone in Atrial Fibrillation
- Dobutamaine Versus Milrinone in Cardiorenal Syndrome
- Oral Contraceptive Therapy and Sexuality
- Comparison of Oral or Intravenous Thiazides vs Tolvaptan in Diuretic Resistant Decompensated Heart Failure
- Mineralocorticoid Receptor Antagonists (MRA) in Heart Failure (HF) and Loop Diuretic Resistance
- Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
- Bioprofiling Response to Mineralocorticoid Receptor Antagonists for the Prevention of Heart Failure
- Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients
- Comparing the Effects of Spironolactone With Chlortalidone on LV Mass in Patients With CKD
- Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease
- The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia
- High-Dose Aldactone for Treatment of Diuretic Resistant Heart Failure
- Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
- Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery
- European Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
- Optimum Treatment for Drug-Resistant Hypertension
- Glucose Metabolism in Subjects With Aldosterone-Producing Adenomas
- Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy
- Comparison of Single and Combination Diuretics in Low-Renin Hypertension
- Early Aldosterone Blockade in Acute Heart Failure: An Exploratory Safety Study
- Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial
- Levosimendan Efficacy Assessment by Cardiopulmonary Exercise Test (CPET)
- The Combination Ambrisentan Plus Spironolactone in Pulmonary Arterial Hypertension Study
- Tissue Sodium in Pre-hypertensive Patients
- Study of High-dose Spironolactone vs. Placebo Therapy in Acute Heart Failure
- Biomarker Guided Therapies in Stage A/B Heart Failure
- A Study of LY2623091 in Participants With High Blood Pressure
- Residual Renal Function Preservation in Peritoneal Dialysis Patients
- Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
- Search of Biomarkers of Mineralocorticoid Receiver Activity : the Value of Neutrophil Gelatinase Associated Lipocalin (NGAL)in Serum or Urine in Human
- Spironolactone Against Anthracycline-induced Cardiomyopathy
- The Effect of Spironolactone on Pain in Older People With Osteoarthritis
- Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
- Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Acetazolamide and Spironolactone to Increase Natriuresis in Congestive Heart Failure
- Sodium-Restricted Diet and Diuretic in the Treatment of Severe Sleep Apnea
- Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart
- Etiology of Sleep Apnea-related Hyperaldosteronism - BP Treatment
- Tolvaptan to Reduce Length of Stay in Hospitalized Patients With Cirrhosis and Hyponatremia
- Early Mineralocorticoid Receptor Antagonist Treatment to Reduce Myocardial Infarct Size
- Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
- L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD
- Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- ALdosterone Antagonist Chronic HEModialysis Interventional Survival Trial
- Use of Spironolactone for the Prevention of Electrolyte Abnormalities in Patients Treated With Amphotericin B
- A Study of LY3045697 After Multiple Oral Dosing in Healthy Participants
- Eplerenone Versus Spironolactone as Treatment of Ascites Due to Liver Cirrhosis; a Study of Efficacy and Side Effects
- Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
- Spironolactone for Pulmonary Arterial Hypertension
- Mineralocorticoid Receptor Antagonists in End Stage Renal Disease
- Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
- Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
- Fludrocortisone and Information Processing in Healthy Volunteers
- Resistant Hypertension Optimal Treatment
- Comparison of Body Weight Change During Contraception With Belara and Yasmin
- The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity
- Evaluation of CLP With and Without Spironolactone in Heart Failure Patients With Chronic Kidney Disease
- Comparison of Eplerenone Versus Spironolactone in Heart Failure Patients With Glucose Intolerance or Type 2 Diabetes
- A Randomized Trial of Carvedilol in Chronic Chagas Cardiomyopathy
- Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis
- Spironolactone Plus Metformin in Polycystic Ovary Syndrome
- Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology
- A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
- Effects of Spironolactone on Collagen Metabolism in Patients With Pulmonary Arterial Hypertension
- Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
- Interest of Topical Spironolactone's Administration to Prevent Corticoid-induced Epidermal Atrophy
- Mineralocorticoid Receptor and Obesity Induced Cardiovascular Complications
- The Effect of Amiloride and Spironolactone in Patients With Hypertension
- Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
- BAY94-8862 Dose Finding Trial in Subjects With Chronic Heart Failure and Mild (Part A) or Moderate (Part B) Chronic Kidney Disease
- A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers
- Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
- Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic Syndrome
- Safety And Efficacy Of Spirinolactone Plus Hydroflumethiazide In The Treatment Of Filipino Patients With Hypertension
- Recurrent Stroke Prevention Clinical Outcome Study
- The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
- Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease
- Evaluation of Patiromer Titration in Heart Failure Patients With Chronic Kidney Disease
- Effects of Spironolactone in Dialysis
- Effect of Aldosterone Blockade on Arterial Compliance
- Pharmacokinetic Study of Spironolactone 25 mg, 50 mg and 100 mg Tablets
- Spironolactone in Adult Congenital Heart Disease
- The Effect of Spironolactone on Blood Pressure in Type-2 Diabetics With Resistant Hypertension
- Aldosterone Blockade Early After Acute Myocardial Infarction
- Fracture Risk With Thiazolidinediones
- Spironolactone and Prevention of Calcineurin Inhibitor Toxicity in Kidney Transplant Recipients
- Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy
- Aldosterone in Diabetic Nephropathy
- Evaluation of Patiromer in Heart Failure Patients
- Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
- Spironolactone and Prevention of Peritoneal Fibrosis in Peritoneal Dialysis
- Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
- Hemodynamic Effects of Spironolactone in Patients With Heart Failure
- The Effect of Amiloride and Spironolactone in Healthy Persons
- Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) Women
- Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular Failure
- Aliskiren and Renin Inhibition in Diastolic Heart Failure
- The Role of Mineralocorticoid Receptors in Vascular Function
- Spironolactone Versus Spironolactone Plus Furosemide (SVSSF)
- A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS
- Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne
- Spironolactone Versus Amiloride as an Add on Agent in Resistant Hypertension
- Spironolactone for Paroxysmal Atrial Fibrillation
- Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
- Effects of Spironolactone on Matrix Metalloproteinases (MMPs) in Heart Failure
- SCREEN-HFI (SCReening Evaluation of the Evolution of New Heart Failure Intervention Study)
- Effect of Aldosterone on Energy Starvation in Heart Failure
- Does Aldosterone Cause Hypertension by a Non-Renal Mechanism?
- Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
- Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension
- Aldosterone Blockade in Heart Failure
- Diurnal Variation of Plasminogen Activator Inhibitor-1
- Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
- Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
- Satavaptan Dose-Ranging Study in the Prevention of Ascites
- Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
- The Efficacy of Spironolactone in Patients With Resistant Hypertension
- Antiremodeling Effect Of Aldosterone Receptors Blockade With Canrenone In Mild Chronic Heart Failure. AREA IN-CHF Study
- Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs Alone
- Improving Outcomes in Patients With Kidney Disease Due to Diabetes
- Effects of Thiazide Diuretics on Sympathetic Nervous System in Hypertension
- Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
- Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis
- Spironolactone Safety in Dialysis Patients
- Spironolactone in Diabetic Nephropathy
- Eplerenone, ACE Inhibition and Albuminuria
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
- Mineralocorticoid Receptor in the Treatment of Severe Depression
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
- Cardiovascular Protective Effect of Spironolactone in Hemodialysis
- Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
- Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
- Prevention of Decompensation in Liver Cirrhosis
- Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics
- Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation
- PHARES Study: Management of Resistant Hypertension
- Spironolactone in Patients With Single Ventricle Heart
- Novel Treatment for Diastolic Heart Failure in Women
- Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
- Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
- Brain Natriuretic Peptide (BNP) to Preserve Renal Function in Hospitalized Patients With Heart Failure
- Renin-angiotensin-aldosterone System (RAAS), Inflammation, and Post-Operative Atrial Fibrillation (AF)
- Larger Dose of Spironolactone for the Treatment of Patients With Nonischemic Cardiomyopathy
- PIE II: Pharmacological Intervention in the Elderly II
- Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney
- Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
- Brain Receptor Function in Post-Traumatic Stress Disorder
- Hypertension Screening and Treatment Program
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
- Treatment of Boys With Precocious Puberty
Clinical trials list
click for details